Benjamin N Rome

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 30

Top Venues

Annals of internal medicine

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics

The New England journal of medicine

Journal of general internal medicine

Brigham and Women's Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Brigham and Women's Hospital Jul 01 2019

United States

Research Fellow :: Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics

Brigham and Women's Hospital

United States

Resident :: Medicine

Publications

Hussain S Lalani, Massimilano Russo, Rishi J Desai, Aaron S Kesselheim, Benjamin N Rome
Association between changes in prices and out-of-pocket costs for brand-name clinician-administered drugs. Health services research (2024)
Alexander C Egilman, Aaron S Kesselheim, Ameet Sarpatwari, Benjamin N Rome
Estimated Medicare Part D Savings From Generic Drugs With a Skinny Label. Annals of internal medicine 177 (6) (2024)
Matthew Vogel, Benjamin N Rome, Aaron S Kesselheim, William B Feldman
Medicare Negotiation's Drug Reformulation Problem. Annals of internal medicine 177 (6) (2024)
Alexander C Egilman, Aaron S Kesselheim, Ameet Sarpatwari, Benjamin N Rome
Estimated Medicare Part D Savings From Generic Drugs With a Skinny Label. Annals of internal medicine (2024)
Benjamin N Rome
Addressing High Drug Prices by Reforming Pharmacy Benefit Managers. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 51 (S2) (2024)
Catherine S Hwang, Aaron S Kesselheim, Benjamin N Rome
Medicare Should Cover Weight Loss Drugs as Long as the Prices are Affordable. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 52 (1) (2024)
Matthew Vogel, Benjamin N Rome, Aaron S Kesselheim, William B Feldman
Medicare Negotiation's Drug Reformulation Problem. Annals of internal medicine 177 (6) (2024)
Alexander C Egilman, Aaron S Kesselheim, Ameet Sarpatwari, Benjamin N Rome
Estimated Medicare Part D Savings From Generic Drugs With a Skinny Label. Annals of internal medicine 177 (6) (2024)
Benjamin N Rome
Addressing High Drug Prices by Reforming Pharmacy Benefit Managers. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 51 (S2) (2024)
Benjamin N Rome
Addressing High Drug Prices by Reforming Pharmacy Benefit Managers. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 51 (S2) (2024)
Matthew Vogel, Benjamin N Rome, Aaron S Kesselheim, William B Feldman
Medicare Negotiation's Drug Reformulation Problem. Annals of internal medicine (2024)
Benjamin N Rome, Simon J Gunter, Aaron S Kesselheim
Market Dynamics of Authorized Generics in Medicaid from 2014 to 2020. Health services research (2023)
Matthew Vogel, Aaron S Kesselheim, William B Feldman, Benjamin N Rome
Will Medicare Price Negotiation Delay Cancer-Drug Launches? The New England journal of medicine (2023)
Benjamin N Rome, Aaron S Kesselheim
Biosimilar Competition for Humira is Here: Signs of Hope Despite Early Hiccups. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Catherine S Hwang, Aaron S Kesselheim, Ameet Sarpatwari, Krista F Huybrechts, Gregory Brill, Benjamin N Rome
Changes in Induced Medical and Procedural Abortion Rates in a Commercially Insured Population, 2018 to 2022 : An Interrupted Time-Series Analysis. Annals of internal medicine (2023)
Christopher Cai, Benjamin N Rome
Reforming Pharmacy Benefit Managers - A Review of Bipartisan Legislation. The New England journal of medicine (2023)
Benjamin N Rome, Simon J Gunter, Aaron S Kesselheim
Market dynamics of authorized generics in Medicaid from 2014 to 2020. Health services research (2023)
Bryan S Walsh, Aaron S Kesselheim, Benjamin N Rome
Medicaid Spending on Antiretrovirals from 2007-2019. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Bryan S Walsh, Aaron S Kesselheim, Ameet Sarpatwari, Benjamin N Rome
Indication-Specific Generic Uptake of Imatinib Demonstrates the Impact of Skinny Labeling. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (10) (2022)
Hussain S Lalani, Aaron S Kesselheim, Benjamin N Rome
Direct-to-Consumer Generic Drugs: A Maverick Approach or Another Exposure of Market Failures? Annals of internal medicine 175 (6) (2022)
Kimberly Feng, Aaron S Kesselheim, Massimiliano Russo, Benjamin N Rome
Patient Out-of-Pocket Costs Following the Availability of Biosimilar Versions of Infliximab. Clinical pharmacology and therapeutics (2022)
Hussain S Lalani, Aaron S Kesselheim, Benjamin N Rome
Potential Medicare Part D Savings on Generic Drugs From the Mark Cuban Cost Plus Drug Company. Annals of internal medicine 175 (7) (2022)
Benjamin N Rome, Aaron S Kesselheim
Reply to Boucher et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 72 (9) (2021)
VÉronique C Raimond, William B Feldman, Benjamin N Rome, Aaron S Kesselheim
Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation. The Milbank quarterly 99 (1) (2021)
William B Feldman, Benjamin N Rome, Jerry Avorn, Aaron S Kesselheim
The Future of Drug-Pricing Transparency. The New England journal of medicine 384 (6) (2021)
Benjamin N Rome, Jerry Avorn, Aaron S Kesselheim
Characteristics of US Patients and Prescribers Using Hydroxychloroquine During the COVID-19 Pandemic. Journal of general internal medicine 36 (12) (2021)
Benjamin N Rome, ChangWon C Lee, Aaron S Kesselheim
Market Exclusivity Length for Drugs with New Generic or Biosimilar Competition, 2012-2018. Clinical pharmacology and therapeutics 109 (2) (2020)
Benjamin N Rome, Jerry Avorn
Drug Evaluation during the Covid-19 Pandemic. The New England journal of medicine 382 (24) (2020)
Benjamin N Rome, Aaron S Kesselheim
Federal Spending on Off-Patent Drugs That Lack Generic Competition. Journal of general internal medicine 36 (3) (2020)
Benjamin N Rome, Jeffrey L Schnipper, Saverio M Maviglia, Stephanie K Mueller
Effect of Shared Electronic Health Records on Duplicate Imaging after Hospital Transfer. Journal of general internal medicine 35 (5) (2019)

Benjamin N Rome.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Benjamin N Rome